For: | Youssef SS, Elfiky A, Nabeel MM, Shousha HI, Elbaz T, Omran D, Marie MS, Elzahry MA, Abul-Fotouh A, Hashem A, Guda MF, Abdelaziz AO. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. World J Hepatol 2022; 14(8): 1562-1575 [PMID: 36157872 DOI: 10.4254/wjh.v14.i8.1562] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i8/1562.htm |
Number | Citing Articles |
1 |
Yasmeen Ishaq, Aqsa Ikram, Badr Alzahrani, Sana Khurshid. The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Insilico Approach. Genes 2022; 14(1): 13 doi: 10.3390/genes14010013
|
2 |
Yanqing Su, Yao Lu, Honglin An, Jinhong Liu, Feimin Ye, Jiayu Shen, Zhuona Ni, Bin Huang, Jiumao Lin. MicroRNA-204-5p Inhibits Hepatocellular Carcinoma by Targeting the Regulator of G Protein Signaling 20. ACS Pharmacology & Translational Science 2023; 6(12): 1817 doi: 10.1021/acsptsci.3c00114
|
3 |
Ermiyas Alemayehu, Alebachew Fasil, Hussen Ebrahim, Zewudu Mulatie, Getachew Mesfin Bambo, Alemu Gedefie, Mulugeta Teshome, Abebaw Worede, Melaku Ashagrie Belete. Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1353547
|
4 |
Fenfen Guo, Hong Li, Jingjing Wang, Jiangfeng Wang, Jinling Zhang, Fanfang Kong, Zemin Zhang, Jinbao Zong. MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential. Cancer Management and Research 2024; : 1491 doi: 10.2147/CMAR.S477698
|